Literature DB >> 30666444

Canceled or aborted CT-guided interventions: 13-year clinical experience at a tertiary care center.

Derya Yakar1, Thomas C Kwee2.   

Abstract

OBJECTIVE: To determine the frequency and causes of canceled or aborted CT-guided interventions (biopsies, cytological aspirations, hookwire localizations, and catheter drainages), associations with patient and procedural variables, and subsequent management.
METHODS: This study included 3052 consecutive CT-guided interventions (2487 biopsies, 80 cytological aspirations, 223 hookwire localizations, and 262 catheter drainages) performed in a single institution within a 13-year period.
RESULTS: Fifty-two of 3052 CT-guided interventions were canceled or aborted, corresponding to a frequency of 1.7% (95% confidence interval [CI] 1.3-2.2%). Main causes in order of decreasing frequency included pain, lack of a safe window for intervention, impossibility to position the co-axial or biopsy needle in or near the target, inability to lie still, dyspnea and low oxygen saturation levels, non-discontinuation of anticoagulant therapy, impossibility to aspirate fluid or pus when attempting drainage, and impossibility to advance the drainage catheter in a fluid collection or abscess. On multivariate analysis, only catheter drainages and head-neck interventions were significantly at risk (p = 0.019 and p = 0.004) to be canceled or aborted, with odds ratios of 2.677 (95% CI 1.178-6.083) and 6.956 (95% CI 1.883-25.691), respectively. Of 52 canceled or aborted CT-guided interventions, 14 (26.9%) were repeated, 19 (36.5%) underwent a different non-CT-guided interventional procedure on the same target, and 19 (36.5%) did not undergo any subsequent intervention.
CONCLUSION: The frequency of canceled or aborted CT-guided interventions is low, but is not negligible. Awareness of causes and circumstances under which they are more likely to occur may reduce the number of canceled or aborted CT-guided interventions. KEY POINTS: • Approximately 1.7% of CT-guided interventions, for which the patient physically shows up at the CT room and which are considered useful by the radiologist, are eventually canceled or aborted. • Main causes (of which some may be prevented) are pain, lack of a safe window, impossibility to position the co-axial or biopsy needle, inability to lie still, dyspnea, non-discontinuation of anticoagulant therapy, and impossibility to aspirate liquid or advance the catheter when attempting drainage. • CT-guided catheter drainages and head-neck interventions are particularly prone to being canceled or aborted.

Entities:  

Keywords:  Biopsy; Cytology; Drainage; Interventional radiology; Multidetector computed tomography

Mesh:

Year:  2019        PMID: 30666444     DOI: 10.1007/s00330-018-5991-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  5 in total

1.  Precise biopsy localization by computer tomography.

Authors:  J R Haaga; R J Alfidi
Journal:  Radiology       Date:  1976-03       Impact factor: 11.105

Review 2.  Interventional CT: 30 years' experience.

Authors:  John R Haaga
Journal:  Eur Radiol       Date:  2005-11       Impact factor: 5.315

3.  Complications in CT-guided procedures: do we really need postinterventional CT control scans?

Authors:  Johanna Nattenmüller; Matthias Filsinger; Mark Bryant; Wolfram Stiller; Boris Radeleff; Lars Grenacher; Hans-Ullrich Kauczor; Waldemar Hosch
Journal:  Cardiovasc Intervent Radiol       Date:  2013-06-19       Impact factor: 2.740

4.  Radiation exposure in CT-guided interventions.

Authors:  Roman Kloeckner; Daniel Pinto dos Santos; Jens Schneider; Levent Kara; Christoph Dueber; Michael B Pitton
Journal:  Eur J Radiol       Date:  2013-08-30       Impact factor: 3.528

5.  Radiation exposure during CT-guided biopsies: recent CT machines provide markedly lower doses.

Authors:  Nika Guberina; Michael Forsting; Adrian Ringelstein; Saravanabavaan Suntharalingam; Kai Nassenstein; Jens Theysohn; Axel Wetter
Journal:  Eur Radiol       Date:  2018-03-28       Impact factor: 5.315

  5 in total
  3 in total

1.  The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.

Authors:  Naila Loudini; Andor W J M Glaudemans; Paul C Jutte; Derya Yakar; Thomas C Kwee
Journal:  Skeletal Radiol       Date:  2020-04-06       Impact factor: 2.199

2.  Computed tomography-guided percutaneous biopsy of head and neck masses: techniques, outcomes, and complications.

Authors:  Mauricio Kauark Amoedo; Chiang Jeng Tyng; Paula Nicole Vieira Pinto Barbosa; Rayssa Araruna Bezerra de Melo; Maria Fernanda Arruda Almeida; Rubens Chojniak; Almir Galvão Vieira Bitencourt
Journal:  Radiol Bras       Date:  2021 Sep-Oct

3.  Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary?

Authors:  Talitha Bent; Derya Yakar; Thomas C Kwee
Journal:  Diagnostics (Basel)       Date:  2021-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.